Skip to main content
Agne Paner, MD, Oncology, Chicago, IL, OSF Healthcare Little Company of Mary Medical Center

AgnePanerMD

Oncology Chicago, IL

Physician

Dr. Paner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Paner's full profile

Already have an account?

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Ascension Illinois/Saint Francis
    Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2004 - 2007
  • Vilnius University Faculty of Medicine
    Vilnius University Faculty of MedicineClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2004 - 2026
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to Action  
    Agne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect

Abstracts/Posters

  • The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Basel...
    Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Impact of Elotuzumab Plus Pomalidomide and Dexamethasone on Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Enrolled in the ELOQUE...
    Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 S...
    Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Quality-of-Life Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab Plus Pomalidomide and Dexamethasone: Results from the Phase 2 Ra... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • A Patient's Guide to Multiple Myeloma
    A Patient's Guide to Multiple MyelomaSeptember 25th, 2019

Hospital Affiliations